Detalles de la búsqueda
1.
Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group).
BMC Cancer
; 22(1): 1324, 2022 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36528772
2.
Esophageal chemoradiotherapy with concurrent nivolumab: Pilot results in the palliative treatment of oligometastatic disease.
Asia Pac J Clin Oncol
; 20(3): 416-422, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38512856
Resultados
1 -
2
de 2
1
Próxima >
>>